SMSbiotech Welcomes New Board of Advisor Member Dr. Jason P. Kirkness
SMSbiotech welcomes new Board of Advisor Member Dr. Jason P. Kirkness Ph.D., a Board of Directors member of the American Thoracic Society (ATS) and Chairperson for their Drug/Device Discovery and Development Committee. The American Thoracic Society is the world’s leading medical society dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education, and advocacy. Core activities of the Society’s more than 16,000 members in 133 countries are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care!
Jason is a highly accomplished executive scientist with a proven track record in pulmonary medicine and leadership roles in prestigious institutions and professional societies. He brings a wealth of experience in medical affairs, clinical affairs, medical device innovation, and industry advisory roles.
He has successfully led over 100 clinical trials and projects, secured multimillion-dollar funding from organizations like NIH and NHMRC, and authored more than 50 high-impact publications. A leader in integrating advanced technologies, such as functional lung imaging, into clinical practice and education, Dr. Kirkness has fostered strategic collaborations with key opinion leaders, healthcare professionals, and global organizations. Renowned for mentoring emerging researchers and clinicians, he continues to drive transformative innovation in respiratory health.
His focus on leveraging technology to advance innovative treatments and next-generation therapies aligns perfectly with SMSbiotech's mission. His work in developing treatment approaches and other platforms has the potential to revolutionize how we address chronic respiratory diseases.
Please join us in welcoming Jason to the SMSbiotech team.
Links for Dr. Jason Kirkness:
